Exocytosis proteins as novel targets for diabetes prevention and/or remediation?
dc.contributor.author | Aslamy, Arianne | |
dc.contributor.author | Thurmond, Debbie C. | |
dc.contributor.department | Cellular and Integrative Physiology, School of Medicine | en_US |
dc.date.accessioned | 2018-10-23T19:40:19Z | |
dc.date.available | 2018-10-23T19:40:19Z | |
dc.date.issued | 2017-05-01 | |
dc.description.abstract | Diabetes remains one of the leading causes of morbidity and mortality worldwide, affecting an estimated 422 million adults. In the US, it is predicted that one in every three children born as of 2000 will suffer from diabetes in their lifetime. Type 2 diabetes results from combinatorial defects in pancreatic β-cell glucose-stimulated insulin secretion and in peripheral glucose uptake. Both processes, insulin secretion and glucose uptake, are mediated by exocytosis proteins, SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) complexes, Sec1/Munc18 (SM), and double C2-domain protein B (DOC2B). Increasing evidence links deficiencies in these exocytosis proteins to diabetes in rodents and humans. Given this, emerging studies aimed at restoring and/or enhancing cellular levels of certain exocytosis proteins point to promising outcomes in maintaining functional β-cell mass and enhancing insulin sensitivity. In doing so, new evidence also shows that enhancing exocytosis protein levels may promote health span and longevity and may also harbor anti-cancer and anti-Alzheimer's disease capabilities. Herein, we present a comprehensive review of the described capabilities of certain exocytosis proteins and how these might be targeted for improving metabolic dysregulation. | en_US |
dc.eprint.version | Final published version | en_US |
dc.identifier.citation | Aslamy A, Thurmond DC. Exocytosis proteins as novel targets for diabetes prevention and/or remediation? American Journal of Physiology Regulatory Integrative and Comparative Physiology. 2017 May 1;312(5):R739-R752. doi: 10.1152/ajpregu.00002.2017 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/17631 | |
dc.language.iso | en_US | en_US |
dc.publisher | American Physiological Society | en_US |
dc.relation.isversionof | 10.1152/ajpregu.00002.2017 | en_US |
dc.relation.journal | American Journal of Physiology Regulatory Integrative and Comparative Physiology | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | PMC | en_US |
dc.subject | SNARE proteins | en_US |
dc.subject | Diabetes | en_US |
dc.subject | Double C2-domain protein B | en_US |
dc.subject | Glucose homeostasis | en_US |
dc.subject | Glucose-stimulated insulin secretion | en_US |
dc.subject | Insulin resistance | en_US |
dc.subject | Syntaxin 4 | en_US |
dc.title | Exocytosis proteins as novel targets for diabetes prevention and/or remediation? | en_US |
dc.type | Article | en_US |
ul.alternative.fulltext | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451566/ | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Exocytosis proteins as novel targets for diabetes prevention and or remediation.pdf
- Size:
- 1.02 MB
- Format:
- Adobe Portable Document Format
- Description:
- Main article
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.99 KB
- Format:
- Item-specific license agreed upon to submission
- Description: